Last Updated: May 23, 2026

Litigation Details for DISH Technologies L.L.C. v. BritBox, LLC (S.D.N.Y. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in DISH Technologies L.L.C. v. BritBox, LLC
The small molecule drugs covered by the patent cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation summary and analysis for: DISH Technologies L.L.C. v. BritBox, LLC (S.D.N.Y. 2023)

Last updated: April 23, 2026

DISH Technologies L.L.C. v. BritBox, LLC (1:23-cv-08971): Litigation Summary and Patent/IP Posture

What is the case and where does it sit in the docket?

Case: DISH Technologies L.L.C. v. BritBox, LLC
Court: U.S. District Court (case number 1:23-cv-08971)
Filing posture: The matter is active on the federal docket as of 2023, with later events tied to motion practice and case management.

What claims are at issue?

The publicly available case record for 1:23-cv-08971 is not sufficient in the material available here to produce an accurate, claim-by-claim litigation summary of:

  • the asserted causes of action (e.g., patent infringement vs. copyright vs. DMCA vs. contract), and
  • the specific rights allegedly infringed, the products/services accused, and the legal theories pleaded.

Because a correct litigation summary requires the actual pleaded counts and any amended complaint language, no complete and accurate claim mapping is provided.

What procedural milestones matter for the infringement/validity battle?

With the available information, only high-level procedural framing can be stated without risking inaccuracies. A complete timeline requires docket entries (complaint, service, answer, claim construction if patent, ECF-referenced filings, hearings, and disposition orders). Those details are not present in the information provided here.

What is the likely litigation posture (based on the parties and typical patterns)?

The parties’ identities suggest a dispute involving pay-TV/distribution and over-the-top content delivery, but that is not enough to state the legal theories or the target rights with required precision.

A business-impact analysis depends on:

  • whether the case is primarily about ownership/authorization (license chain), access controls, retransmission/streaming, or technical circumvention;
  • whether the defendant has raised defenses that typically drive early motion outcomes (jurisdiction, standing, lack of infringement, license, exhaustion, preemption, fair use, etc.);
  • whether the case targets specific infrastructure (headend, apps, receivers, AD insertion, manifesting, DRM, player SDK).

Those specifics require docket-level and pleading-level facts that are not supplied here.


What does the record show on injunction risk and damages exposure?

A litigation-and-investment view depends on whether the plaintiff seeks:

  • a preliminary injunction (and whether the court granted, denied, or narrowed it),
  • statutory damages (if applicable), or
  • a reasonable royalty / lost profits theory (if patent infringement) with a damages period and apportionment.

Those elements are not accessible from the information provided here in a way that supports a complete and accurate answer.


What is the strongest actionable business question this case answers?

Without verified details of the asserted rights and procedural posture, the only actionable conclusion is structural: this case is being handled in federal court with ongoing docket activity, and the outcome will hinge on the pleaded legal theories and the court’s rulings on the early dispositive motions (if any) and any request for injunctive relief.


Claim chart, patents-in-suit, and technical infringement analysis: included or excluded?

No reliable identification of:

  • patents-in-suit,
  • independent claim numbers,
  • accused instrumentalities,
  • infringement contentions,
  • claim construction inputs,
  • validity challenges, is available in the information provided here.

Accordingly, a claim chart or technical infringement/validity breakdown is not produced.


Litigation risk matrix for DISH vs. BritBox (what can be stated with certainty from available data)

Risk Dimension DISH Technologies L.L.C. BritBox, LLC
Core liability theory Not stated in available material Not stated in available material
Early motion likelihood (12(b), venue, injunction) Not stated in available material Not stated in available material
Damages/injunctive exposure basis Not stated in available material Not stated in available material
Settlement leverage Not stated in available material Not stated in available material
Practical path to resolution Not stated in available material Not stated in available material

Key Takeaways

  • Case: DISH Technologies L.L.C. v. BritBox, LLC, 1:23-cv-08971 is a federal litigation matter in which the actionable details depend on docket entries and the pleaded claims.
  • Missing from provided record: Specific claims/cause(s) of action, any patents-in-suit or asserted IP rights, and the procedural milestones that drive outcome probability (injunction motions, dispositive motions, claim construction or scheduling orders).
  • Result: A complete litigation summary and patent/IP analysis cannot be produced accurately from the information available here.

FAQs

  1. What is the dispute about in one sentence?
    A federal lawsuit between DISH Technologies L.L.C. and BritBox, LLC under case number 1:23-cv-08971, with details requiring docket and pleading review to summarize accurately.

  2. Is this a patent case?
    The material provided does not identify patents-in-suit or whether the asserted claims include patent infringement.

  3. Has the court ruled on any injunction request?
    No injunction outcome is stated in the provided information.

  4. What are the main defenses typically used in cases like this?
    Defense set and viability cannot be stated without the actual pleaded claims and the motion practice reflected in the docket.

  5. What is the investment takeaway?
    Until the pleaded rights and the procedural rulings are known, the case’s litigation leverage, damages exposure, and business impact cannot be quantified from the available record.


References (APA)

[1] U.S. District Court docket for DISH Technologies L.L.C. v. BritBox, LLC, 1:23-cv-08971.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.